Vienna
Austria
28
2025-10-09
The entities that hold a legal rights for patent applications filed by inventor Gollner Andreas:
Andreas Gollner from Vienna, AT has applied for patents for these inventions. The list has both pending applications and granted patents:
ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER
#2 | 2025-09-25ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER
#3 | 2025-05-22HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF CANCER
#4 | 2025-05-08KRAS DEGRADING COMPOUNDS COMPRISING ANNULATED 2-AMINO-3-CYANO THIOPHENES
#5 | 2025-04-24ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER
#6 | 2025-01-16SPIROCYCLIC ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER
#7 | 2025-01-02ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER
#8 | 2025-01-02ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER
#9 | 2024-05-30Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer
#10 | 2024-04-04Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors
#11 | 2023-07-20ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER
#12 | 2023-07-06ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER
#13 | 2022-05-12Isoindolinone substituted indoles and derivatives as RAS inhibitors
#14 | 2021-12-16Phenyltetrazole derivatives as plasma kallikrein inhibitors
#15 | 2021-12-09Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer
#16 | 2021-04-08NEW SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS
#17 | 2021-01-05Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
#18 | 2020-02-20Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors
#19 | 2019-06-06Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors
#20 | 2018-10-25Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
#21 | 2018-10-11NEW SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS
#22 | 2018-09-27Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
#23 | 2017-08-31Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors
#24 | 2017-06-22Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
#25 | 2016-02-25SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS
#26 | 2016-01-07Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
#27 | 2015-10-15Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
#28 | 2014-08-28UNIQUE HALOGEN-INDUCED CYCLIZATIONS, REAGENTS THEREFOR, AND COMPOUNDS PRODUCED THEREBY
890008 ⎘